Zimmer Biomet Holdings ROA 2006-2019 | ZBH

Current and historical return on assets (ROA) values for Zimmer Biomet Holdings (ZBH) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Zimmer Biomet Holdings ROA for the three months ending September 30, 2019 was 6.59%.
Zimmer Biomet Holdings ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2019-09-30 $-0.09B $24.32B -0.37%
2019-06-30 $-0.36B $24.21B -1.47%
2019-03-31 $-0.31B $24.29B -1.24%
2018-12-31 $-0.38B $24.13B -1.48%
2018-09-30 $1.75B $25.38B 6.74%
2018-06-30 $1.69B $25.49B 6.43%
2018-03-31 $1.69B $27.18B 6.37%
2017-12-31 $1.81B $26.01B 6.85%
2017-09-30 $0.65B $26.42B 2.45%
2017-06-30 $0.71B $26.46B 2.66%
2017-03-31 $0.50B $26.99B 1.86%
2016-12-31 $0.31B $26.68B 1.16%
2016-09-30 $0.36B $27.04B 1.37%
2016-06-30 $0.23B $25.97B 0.86%
2016-03-31 $0.08B $26.30B 0.31%
2015-12-31 $0.15B $27.16B 0.59%
2015-09-30 $0.17B $26.69B 0.83%
2015-06-30 $0.32B $27.20B 2.00%
2015-03-31 $0.67B $17.19B 5.81%
2014-12-31 $0.72B $9.66B 7.52%
2014-09-30 $0.83B $9.67B 8.64%
2014-06-30 $0.81B $9.64B 8.52%
2014-03-31 $0.78B $9.38B 8.37%
2013-12-31 $0.78B $9.58B 8.48%
2013-09-30 $0.68B $9.36B 7.49%
2013-06-30 $0.70B $9.10B 7.88%
2013-03-31 $0.77B $8.75B 8.70%
2012-12-31 $0.76B $9.01B 8.64%
2012-09-30 $0.76B $8.78B 8.81%
2012-06-30 $0.77B $8.62B 9.12%
2012-03-31 $0.76B $8.60B 9.09%
2011-12-31 $0.76B $8.52B 9.21%
2011-09-30 $0.64B $8.20B 7.86%
2011-06-30 $0.64B $8.25B 7.90%
2011-03-31 $0.60B $8.12B 7.52%
2010-12-31 $0.60B $8.00B 7.54%
2010-09-30 $0.72B $8.00B 9.12%
2010-06-30 $0.68B $7.83B 8.70%
2010-03-31 $0.72B $7.82B 9.38%
2009-12-31 $0.72B $7.79B 9.52%
2009-09-30 $0.73B $7.65B 9.87%
2009-06-30 $0.80B $7.46B 10.96%
2009-03-31 $0.81B $7.23B 11.40%
2008-12-31 $0.85B $7.24B 12.05%
2008-09-30 $0.95B $7.08B 13.71%
2008-06-30 $0.78B $6.94B 11.54%
2008-03-31 $0.78B $6.92B 11.89%
2007-12-31 $0.77B $6.63B 12.18%
2007-09-30 $0.76B $6.37B 12.20%
2007-06-30 $0.89B $6.32B 14.70%
2007-03-31 $0.86B $6.10B 14.40%
2006-12-31 $0.84B $5.97B 14.05%
2006-09-30 $0.79B $5.91B 13.44%
2006-06-30 $0.78B $5.96B 13.36%
2006-03-31 $0.77B $5.92B 13.43%
2005-12-31 $0.73B $5.72B 13.06%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $30.725B $7.933B
Zimmer Biomet Holdings, Inc. is a musculoskeletal healthcare company. The company design, manufacture and market orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products. Zimmer Biomet Holdings, Inc., formerly known as Zimmer Holdings, Inc., is based in Warsaw, United States.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $159.545B 22.04
Abbott Laboratories (ABT) United States $157.393B 28.71
Stryker (SYK) United States $79.374B 26.69
Boston Scientific (BSX) United States $61.719B 29.13
Baxter (BAX) United States $45.812B 27.78
Essilor Luxottica (ESLOY) France $35.128B 0.00
Lonza Group Ag (LZAGY) Switzerland $28.134B 0.00
Coloplast (CLPBY) Denmark $27.648B 42.67
Terumo (TRUMY) Japan $26.986B 33.68
ResMed (RMD) United States $23.088B 42.59
Smith & Nephew SNATS (SNN) United Kingdom $21.557B 0.00
Sunny Optical Technology (SNPTF) China $20.017B 0.00
Insulet (PODD) United States $11.669B 555.18
Bio-Rad Laboratories (BIO) United States $11.282B 54.15
Canopy Growth (CGC) Canada $8.676B 0.00
Perrigo (PRGO) Ireland $8.033B 14.98
William Demant Holdings (WILYY) Denmark $7.896B 0.00
Hill-Rom Holdings (HRC) United States $7.750B 22.78
DiaSorin S.p.A (DSRLF) Italy $7.357B 0.00
GN STORE NORD (GNNDY) Denmark $6.158B 31.81
Haemonetics (HAE) United States $5.770B 38.99
Shandong Weigao Medical Polymer (SHWGF) China $5.020B 0.00
NuVasive (NUVA) United States $4.065B 32.01
ICU Medical (ICUI) United States $3.960B 25.81
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.923B 0.00
Neogen (NEOG) United States $3.757B 62.53
GW Pharmaceuticals (GWPH) United Kingdom $3.675B 0.00
Agios Pharmaceuticals (AGIO) United States $3.113B 0.00
Quidel (QDEL) United States $3.020B 28.66
National Vision Holdings (EYE) United States $2.597B 58.63
Aurora Cannabis (ACB) Canada $2.321B 0.00
Cardiovascular Systems (CSII) United States $1.887B 0.00
AtriCure (ATRC) United States $1.513B 0.00
InMode (INMD) Israel $1.440B 0.00
TG Therapeutics (TGTX) United States $1.364B 0.00
Aphria (APHA) $1.331B 0.00
VAREX IMAGING (VREX) United States $1.206B 24.09
NanoString Technologies (NSTG) United States $1.101B 0.00
Phibro Animal Health (PAHC) United States $1.043B 19.54
PetIQ (PETQ) United States $0.869B 21.20
Eagle Pharmaceuticals (EGRX) United States $0.806B 30.87
Lantheus Holdings (LNTH) United States $0.742B 18.54
LeMaitre Vascular (LMAT) United States $0.737B 41.43
Omeros (OMER) United States $0.678B 0.00
Quanterix (QTRX) United States $0.675B 0.00
Cerus (CERS) United States $0.571B 0.00
Surmodics (SRDX) United States $0.560B 58.06
MacroGenics (MGNX) United States $0.551B 0.00
Organigram Holdings (OGI) Canada $0.509B 0.00
OraSure Technologies (OSUR) United States $0.507B 30.44
HEXO (HEXO) $0.441B 0.00
Meridian Bioscience (VIVO) United States $0.424B 14.54
Utah Medical Products (UTMD) United States $0.392B 28.37
Zynex (ZYXI) United States $0.350B 39.59
Owens & Minor (OMI) United States $0.346B 12.81
BioLife Solutions (BLFS) United States $0.332B 135.08
Neptune Wellness Solutions (NEPT) Canada $0.285B 0.00
Bovie Medical (APYX) United States $0.277B 0.00
Female Health (VERU) United States $0.273B 0.00
Vapotherm (VAPO) United States $0.259B 0.00
United Health Products (UEEC) United States $0.233B 0.00
Repro-Med Systems (KRMD) United States $0.225B 0.00
Viemed Healthcare (VMD) United States $0.209B 22.04
Green Organic Dutchman Holdings (TGODF) Canada $0.178B 0.00
Liberty Health Sciences (LHSIF) Canada $0.177B 0.00
Rockwell Medical (RMTI) United States $0.166B 0.00
Cytosorbents (CTSO) United States $0.149B 0.00
Fonar (FONR) United States $0.134B 9.43
Chimerix (CMRX) United States $0.125B 0.00
MTech Acquisition (KERN) United States $0.097B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.095B 0.00
Surface Oncology (SURF) United States $0.094B 0.00
United-Guardian (UG) United States $0.089B 22.57
MRI Interventions (MRIC) United States $0.086B 0.00
Nephros (NEPH) United States $0.074B 0.00
Chembio Diagnostics (CEMI) United States $0.069B 0.00
FSD PHARMA INC (HUGE) $0.051B 0.00
ImmuCell (ICCC) United States $0.036B 0.00
Trinity Biotech (TRIB) Ireland $0.025B 0.00
GUARDION HEALTH (GHSI) United States $0.023B 0.00
NF Energy Saving (BIMI) China $0.023B 0.00
Senestech (SNES) United States $0.016B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.014B 0.00
Capricor Therapeutics (CAPR) United States $0.008B 0.00
Valeritas Holdings (VLRX) United States $0.007B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00
Akers Biosciences Inc (AKER) United States $0.002B 0.00